News >

Debate Continues Between Upfront Surgery and Neoadjuvant Chemo in Advanced Ovarian Cancer

Caroline Seymour
Published: Tuesday, Jul 16, 2019

R. Wendel Naumann, MD, director of Minimally Invasive Surgery in Gynecologic Oncology at Carolinas Medical Center, Atrium Health

R. Wendel Naumann, MD

Primary debulking surgery is standard for patients with newly diagnosed advanced ovarian cancer, but for those who are not candidates for the procedure, neoadjuvant chemotherapy and interval debulking surgery can be used without sacrificing outcomes, said R. Wendel Naumann, MD. 
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication
x